Katalog
Hilfe
Bauen Sie hier Ihr Portfolio auf
Geben Sie die Menge neben den benötigten Aktien ein – Ihr Portfolio wird automatisch erstellt.
Schneller Screener: nach Kategorie und Empfehlung filtern, Fundamentaldaten, Kennzahlen und Unternehmensprofile überprüfen.
| Unternehmen | Kategorie | Preis | Δ% | Div% | Vol20 | EPS(TTM) | QoQ | EPS(SPR) | Stil | Horizont | Pot. | Risiko | Empfehlung | Portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbott Laboratories (ABT) | Pharma | 103.10 | 0.00% | 2.7% | 2.8% | 3.60 | -2.6% | 0.0% | Ausgewogen | Mittel | 60 | 51 | Halten |
|
| AbbVie (ABBV) | Pharma | 259.29 | 0.00% | 3.7% | 1.6% | 2.04 | -9.7% | 2.3% | Wachstum | Mittel | 69 | 40 | Kaufen |
|
| Amneal Pharmaceuticals (AMRX) | Pharma | 17.92 | 0.00% | 0.0% | 1.8% | 0.38 | -11.3% | 0.0% | Wert | Mittel | 67 | 65 | Halten |
|
| Amphastar Pharmaceuticals (AMPH) | Pharma | 18.72 | 0.00% | 0.0% | 0.0% | 1.71 | -6.5% | 0.0% | Wert | Mittel | 30 | 70 | Verkaufen |
|
| AstraZeneca (AZN) | Pharma | 169.26 | 0.00% | 1.5% | 2.6% | 6.71 | -1.4% | 2.4% | Wachstum | Mittel | 40 | 70 | Verkaufen |
|
| Avadel Pharmaceuticals (AVDL) | Pharma | 21.64 | 0.00% | 0.0% | 0.0% | 0.00 | 13.7% | -162.5% | Wachstum | Mittel | 58 | 70 | Verkaufen |
|
| Bausch Health (BHC) | Pharma | 4.43 | 0.00% | 0.0% | 1.8% | -3.21 | -12.3% | -3.7% | Wachstum | Mittel | 20 | 85 | Verkaufen |
|
| Bayer (BAYRY) | Pharma | 13.13 | 0.00% | 0.2% | 2.6% | -0.53 | 20.3% | 23.4% | Wachstum | Mittel | 40 | 70 | Verkaufen |
|
| Centessa Pharmaceuticals (CNTA) | Pharma | 40.50 | 0.00% | 93.8% | 0.0% | -1.78 | 0.0% | -36.8% | Wachstum | Mittel | 30 | 70 | Verkaufen |
|
| Compass Pathways (CMPS) | Pharma | 11.26 | 0.00% | 0.0% | 3.6% | -2.15 | 0.0% | 33.3% | Wachstum | Mittel | 40 | 70 | Verkaufen |
|
| CoreSite (COR) | Pharma | 309.89 | 0.00% | 0.8% | 1.5% | 13.12 | -8.8% | -1.5% | Wachstum | Mittel | 40 | 70 | Verkaufen |
|
| Dr. Reddy's Laboratories (RDY) | Pharma | 11.79 | 0.00% | 0.0% | 0.0% | 39.83 | 6.4% | -34.7% | Wert | Mittel | 30 | 70 | Verkaufen |
|
| Eli Lilly (LLY) | Pharma | 1196.04 | 0.00% | 0.7% | 1.6% | 28.20 | 2.6% | 22.7% | Wachstum | Lang | 83 | 28 | Kaufen |
|
| Gilead Sciences (GILD) | Pharma | 129.31 | 0.00% | 3.2% | 2.1% | 7.42 | -12.2% | 6.3% | Wachstum | Mittel | 46 | 70 | Halten |
|
| GSK (GSK) | Pharma | 51.35 | 0.00% | 3.5% | 1.7% | 3.42 | -11.5% | 6.9% | Wachstum | Mittel | 43 | 65 | Verkaufen |
|
| Incyte (INCY) | Pharma | 117.67 | 0.00% | 0.0% | 1.2% | 7.30 | -15.5% | 31.2% | Wachstum | Mittel | 69 | 41 | Kaufen |
|
| Johnson & Johnson (JNJ) | Pharma | 263.40 | 0.00% | 2.3% | 1.6% | 8.67 | -2.0% | 0.7% | Ausgewogen | Mittel | 69 | 40 | Kaufen |
|
| Ligand Pharmaceuticals (LGND) | Pharma | 300.53 | 0.00% | 0.0% | 1.8% | 7.84 | -13.3% | -11.4% | Wachstum | Mittel | 45 | 70 | Verkaufen |
|
| Merck (MRK) | Pharma | 131.07 | 0.00% | 2.6% | 1.8% | 3.56 | -0.2% | 1.5% | Wachstum | Lang | 70 | 40 | Kaufen |
|
| Moderna (MRNA) | Pharma | 54.07 | 0.00% | 0.0% | 4.4% | -8.15 | -42.6% | 60.9% | Wachstum | Mittel | 39 | 76 | Verkaufen |
|
| Novartis (NVS) | Pharma | 155.01 | 0.00% | 4.1% | 1.6% | 7.02 | 1.4% | 2.0% | Wachstum | Lang | 67 | 40 | Kaufen |
|
| Novo Nordisk (NVO) | Pharma | 48.77 | 0.00% | 4.3% | 1.6% | 27.45 | 22.3% | 11.1% | Wachstum | Mittel | 70 | 40 | Kaufen |
|
| Organon & Co (OGN) | Pharma | 13.52 | 0.00% | 0.6% | 0.2% | 0.95 | -3.1% | -14.5% | Wachstum | Mittel | 40 | 69 | Verkaufen |
|
| Pfizer (PFE) | Pharma | 24.54 | 0.00% | 8.6% | 1.2% | 1.31 | -17.7% | 3.9% | Wachstum | Mittel | 40 | 70 | Verkaufen |
|
| Revolution Medicines (RVMD) | Pharma | 189.23 | 0.00% | 0.0% | 1.7% | -7.11 | 0.0% | -25.1% | Wachstum | Mittel | 42 | 70 | Verkaufen |
|
| Roche (RHHBY) | Pharma | 54.70 | 0.00% | 2.8% | 1.9% | 2.84 | 2.3% | 5.1% | Wachstum | Lang | 68 | 42 | Kaufen |
|
| Sanofi (SNY) | Pharma | 43.35 | 0.00% | 5.5% | 1.3% | 1.94 | -7.9% | 0.0% | Wert | Mittel | 45 | 62 | Halten |
|
| Teva Pharmaceutical Industries (TEVA) | Pharma | 30.81 | 0.00% | 0.0% | 1.9% | 1.37 | -15.5% | 6.0% | Ausgewogen | Mittel | 30 | 70 | Verkaufen |
|
| Vertex Pharmaceuticals (VRTX) | Pharma | 477.36 | 0.00% | 0.0% | 1.9% | 17.01 | -7.4% | 5.4% | Wachstum | Mittel | 60 | 67 | Halten |
|
| Viatris (VTRS) | Pharma | 17.24 | 0.00% | 3.4% | 1.8% | -0.26 | -5.0% | 7.1% | Ausgewogen | Mittel | 55 | 68 | Verkaufen |
|